Get in-depth coverage of current and future trends in technology, and how they are shaping business, entertainment, communications, science, politics, and society.
…
continue reading
Content provided by TheoryLab and American Cancer Society. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by TheoryLab and American Cancer Society or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.
Player FM - Aplicație Podcast
Treceți offline cu aplicația Player FM !
Treceți offline cu aplicația Player FM !
Two NYU scientists on melanoma, lung cancer, challenges, and research dreams
MP3•Pagina episodului
Manage episode 291254739 series 2681705
Content provided by TheoryLab and American Cancer Society. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by TheoryLab and American Cancer Society or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.
At first glance, the work of Eva Hernando and Thales Papagiannakopoulos might not seem to have much in common. Dr. Hernando studies the contributions of non-genetic alterations to the aggressive behavior of melanoma. Dr. Papagiannakopoulos is applying CRISPR/Cas9 to study lung cancer. But in this conversation, Drs. Hernando and Papagiannakopoulos take us through the ins and outs of their research into why cancer grows and spreads, and we learn how they learn from each other, how NYU Grossman School of Medicine encourages collaboration, and why new directions in cancer research have them feeling optimistic. 3:05 – Eva Hernando, PhD, is Professor in the Department of Pathology and Assistant Dean for Research at the NYU Grossman School of Medicine. Thales Papagiannakopoulos, PhD, is Associate Professor in the Department of Pathology at NYU Grossman School of Medicine. 5:26 – Dr. Hernando on why cancer cells metastasize 10:10 – Why she studies metastasis in melanoma 13:28 – Dr. Papagiannakopoulos on why it’s so hard to understand what the cancer genome is telling us 20:50 – Dr. Papagiannakopoulos on why he studies lung cancer 23:32 – Dr. Hernando on the biggest challenge she’s facing as a melanoma researcher 27:42 – Dr. Papagiannakopoulos on new directions in lung cancer research 30:34 – On encouraging research collaborations at NYU 35:16 – How ACS funding has impacted their cancer research
…
continue reading
139 episoade
MP3•Pagina episodului
Manage episode 291254739 series 2681705
Content provided by TheoryLab and American Cancer Society. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by TheoryLab and American Cancer Society or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.
At first glance, the work of Eva Hernando and Thales Papagiannakopoulos might not seem to have much in common. Dr. Hernando studies the contributions of non-genetic alterations to the aggressive behavior of melanoma. Dr. Papagiannakopoulos is applying CRISPR/Cas9 to study lung cancer. But in this conversation, Drs. Hernando and Papagiannakopoulos take us through the ins and outs of their research into why cancer grows and spreads, and we learn how they learn from each other, how NYU Grossman School of Medicine encourages collaboration, and why new directions in cancer research have them feeling optimistic. 3:05 – Eva Hernando, PhD, is Professor in the Department of Pathology and Assistant Dean for Research at the NYU Grossman School of Medicine. Thales Papagiannakopoulos, PhD, is Associate Professor in the Department of Pathology at NYU Grossman School of Medicine. 5:26 – Dr. Hernando on why cancer cells metastasize 10:10 – Why she studies metastasis in melanoma 13:28 – Dr. Papagiannakopoulos on why it’s so hard to understand what the cancer genome is telling us 20:50 – Dr. Papagiannakopoulos on why he studies lung cancer 23:32 – Dr. Hernando on the biggest challenge she’s facing as a melanoma researcher 27:42 – Dr. Papagiannakopoulos on new directions in lung cancer research 30:34 – On encouraging research collaborations at NYU 35:16 – How ACS funding has impacted their cancer research
…
continue reading
139 episoade
Toate episoadele
×Bun venit la Player FM!
Player FM scanează web-ul pentru podcast-uri de înaltă calitate pentru a vă putea bucura acum. Este cea mai bună aplicație pentru podcast și funcționează pe Android, iPhone și pe web. Înscrieți-vă pentru a sincroniza abonamentele pe toate dispozitivele.